AKRO logo

Akero Therapeutics (AKRO) Free cash flow

annual FCF:

-$231.11M-$85.74M(-58.98%)
December 31, 2024

Summary

  • As of today (July 1, 2025), AKRO annual free cash flow is -$231.11 million, with the most recent change of -$85.74 million (-58.98%) on December 31, 2024.
  • During the last 3 years, AKRO annual FCF has fallen by -$151.43 million (-190.04%).
  • AKRO annual FCF is now -2301.10% below its all-time high of -$9.63 million, reached on December 31, 2018.

Performance

AKRO Free cash flow Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAKROcash flow metrics

quarterly FCF:

-$67.66M-$574.00K(-0.86%)
March 31, 2025

Summary

  • As of today (July 1, 2025), AKRO quarterly free cash flow is -$67.66 million, with the most recent change of -$574.00 thousand (-0.86%) on March 31, 2025.
  • Over the past year, AKRO quarterly FCF has dropped by -$32.52 million (-92.56%).
  • AKRO quarterly FCF is now -19918.93% below its all-time high of -$338.00 thousand, reached on March 31, 2018.

Performance

AKRO quarterly FCF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAKROcash flow metrics

TTM FCF:

-$263.63M-$32.52M(-14.07%)
March 31, 2025

Summary

  • As of today (July 1, 2025), AKRO TTM free cash flow is -$263.63 million, with the most recent change of -$32.52 million (-14.07%) on March 31, 2025.
  • Over the past year, AKRO TTM FCF has dropped by -$107.75 million (-69.13%).
  • AKRO TTM FCF is now -77897.04% below its all-time high of -$338.00 thousand, reached on March 31, 2018.

Performance

AKRO TTM FCF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAKROcash flow metrics

Free cash flow Formula

FCF = Cash From Operations − CAPEX

AKRO Free cash flow Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-59.0%-92.6%-69.1%
3 y3 years-190.0%-195.8%-213.1%
5 y5 years-548.7%-497.9%-348.6%

AKRO Free cash flow Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-190.0%at low-246.8%+3.9%-215.0%at low
5 y5-year-548.7%at low-395.7%+3.9%-348.6%at low
alltimeall time-2301.1%at low<-9999.0%+3.9%<-9999.0%at low

AKRO Free cash flow History

DateAnnualQuarterlyTTM
Mar 2025
-
-$67.66M(+0.9%)
-$263.63M(+14.1%)
Dec 2024
-$231.11M(+59.0%)
-$67.09M(-4.7%)
-$231.11M(+8.7%)
Sep 2024
-
-$70.42M(+20.5%)
-$212.64M(+10.8%)
Jun 2024
-
-$58.45M(+66.3%)
-$191.94M(+23.1%)
Mar 2024
-
-$35.14M(-27.7%)
-$155.88M(+7.2%)
Dec 2023
-$145.37M(+57.1%)
-$48.63M(-2.2%)
-$145.37M(+18.9%)
Sep 2023
-
-$49.72M(+122.1%)
-$122.25M(+25.8%)
Jun 2023
-
-$22.39M(-9.1%)
-$97.15M(+3.1%)
Mar 2023
-
-$24.63M(-3.4%)
-$94.27M(+1.9%)
Dec 2022
-$92.52M(+16.1%)
-$25.51M(+3.6%)
-$92.52M(-1.3%)
Sep 2022
-
-$24.62M(+26.2%)
-$93.70M(+12.0%)
Jun 2022
-
-$19.51M(-14.7%)
-$83.69M(-0.6%)
Mar 2022
-
-$22.88M(-14.3%)
-$84.21M(+5.7%)
Dec 2021
-$79.68M
-$26.70M(+82.8%)
-$79.68M(+4.3%)
DateAnnualQuarterlyTTM
Sep 2021
-
-$14.61M(-27.1%)
-$76.39M(+1.3%)
Jun 2021
-
-$20.03M(+9.2%)
-$75.43M(-3.3%)
Mar 2021
-
-$18.35M(-21.6%)
-$77.98M(+9.9%)
Dec 2020
-$70.95M(+99.2%)
-$23.40M(+71.4%)
-$70.95M(+19.8%)
Sep 2020
-
-$13.65M(-39.6%)
-$59.20M(+0.7%)
Jun 2020
-
-$22.58M(+99.6%)
-$58.76M(+41.6%)
Mar 2020
-
-$11.32M(-2.9%)
-$41.50M(+16.5%)
Dec 2019
-$35.63M(+270.2%)
-$11.65M(-11.8%)
-$35.63M(+36.7%)
Sep 2019
-
-$13.21M(+148.3%)
-$26.05M(+76.0%)
Jun 2019
-
-$5.32M(-2.2%)
-$14.80M(+0.5%)
Mar 2019
-
-$5.44M(+162.4%)
-$14.73M(+53.0%)
Dec 2018
-$9.63M
-$2.08M(+5.8%)
-$9.63M(+27.5%)
Sep 2018
-
-$1.96M(-62.7%)
-$7.55M(+35.1%)
Jun 2018
-
-$5.25M(+1453.6%)
-$5.59M(+1553.6%)
Mar 2018
-
-$338.00K
-$338.00K

FAQ

  • What is Akero Therapeutics annual free cash flow?
  • What is the all time high annual FCF for Akero Therapeutics?
  • What is Akero Therapeutics annual FCF year-on-year change?
  • What is Akero Therapeutics quarterly free cash flow?
  • What is the all time high quarterly FCF for Akero Therapeutics?
  • What is Akero Therapeutics quarterly FCF year-on-year change?
  • What is Akero Therapeutics TTM free cash flow?
  • What is the all time high TTM FCF for Akero Therapeutics?
  • What is Akero Therapeutics TTM FCF year-on-year change?

What is Akero Therapeutics annual free cash flow?

The current annual FCF of AKRO is -$231.11M

What is the all time high annual FCF for Akero Therapeutics?

Akero Therapeutics all-time high annual free cash flow is -$9.63M

What is Akero Therapeutics annual FCF year-on-year change?

Over the past year, AKRO annual free cash flow has changed by -$85.74M (-58.98%)

What is Akero Therapeutics quarterly free cash flow?

The current quarterly FCF of AKRO is -$67.66M

What is the all time high quarterly FCF for Akero Therapeutics?

Akero Therapeutics all-time high quarterly free cash flow is -$338.00K

What is Akero Therapeutics quarterly FCF year-on-year change?

Over the past year, AKRO quarterly free cash flow has changed by -$32.52M (-92.56%)

What is Akero Therapeutics TTM free cash flow?

The current TTM FCF of AKRO is -$263.63M

What is the all time high TTM FCF for Akero Therapeutics?

Akero Therapeutics all-time high TTM free cash flow is -$338.00K

What is Akero Therapeutics TTM FCF year-on-year change?

Over the past year, AKRO TTM free cash flow has changed by -$107.75M (-69.13%)
On this page